Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Clinical trial NCT00771394 · COMPLETED

Trial details

NCT number: NCT00771394
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia Benign Prostatic Hypertrophy Overactive Bladder

Start date: 2008-10-01
Primary completion: 2010-01-01
Enrollment: 638

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.